Effects of Z-FA.FMK on D-galactosamine/tumor necrosis factor-alpha-induced kidney injury and oxidative stress in mice : effects of Z-FA.FMK on TNF-alpha-mediated kidney injury.
The aim of this investigation was to demonstrate that benzyloxicarbonyl-L-phenylalanyl-alanine-fluoromethylketone (Z-FA.FMK), which is a pharmacological inhibitor of cathepsin B, has protective role on the kidney injury that occurs together with liver injury. Methods BALB/c male mice used in this study were divided into four groups. The first group was given physiologic saline only, the second group was administered Z-FA.FMK alone, the third group received D: -galactosamine and tumor necrosis factor-alpha (D-GalN/TNF-alpha), and the fourth group was given both D-GalN/TNF-alpha and Z-FA.FMK. One hour after administration of 8 mg/kg Z-FA.FMK by intravenous injection, D-GalN (700 mg/kg) and TNF-alpha (15 microg/kg) were given by intraperitoneal injection. Results In the group given D-GalN/TNF-alpha, the following results were found: severe degenerative morphological changes in the kidney tissue, a significant increase in the number of activated caspase-3-positive tubular epithelial cell, an insignificant increase in the number of proliferating cell nuclear antigen (PCNA)-positive tubular epithelial cell, a decrease in the kidney glutathione (GSH) levels, catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities, an increase in the kidney lipid peroxidation (LPO) levels, lactate dehydrogenase (LDH) activity, serum aspartate aminotransferase (AST), and alanine aminotransferase (ALT) activities, uric acid and urea levels. In contrast, in the group given D-GalN/TNF-alpha and Z-FA.FMK, a significant decrease in the D-GalN/TNF-alpha-induced degenerative changes, a decrease in the number of activated caspase-3-positive tubular epithelial cell, a insignificant decrease in the number of PCNA-positive tubular epithelial cell, an increase in the kidney GSH levels, CAT, SOD and GPx activities, a decrease in the kidney LPO levels, LDH activity, serum AST and ALT activities, uric acid and urea levels were determined. Conclusion These results suggest that pretreatment with Z-FA.FMK markedly lessens the degree of impairment seen in D-GalN/TNF-alpha-induced kidney injury, which occurred together with liver injury in mice.
Gezginci-Oktayoglu
Selda
S
Faculty of Science, Department of Biology, Istanbul University, Vezneciler, Istanbul 34134, Turkey.
Tunali
Sevim
S
Yanardag
Refiye
R
Bolkent
Sehnaz
S
D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D053148:Caspase 3 / Q000378:metabolism; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology*; D004151:Dipeptides / Q000494:pharmacology*; D004789:Enzyme Activation / Q000187:drug effects; D005688:Galactosamine / Q000633:toxicity*; D005978:Glutathione / Q000378:metabolism; D007150:Immunohistochemistry; D007659:Ketones / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D007674:Kidney Diseases / Q000201:enzymology / Q000473:pathology*; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D018384:Oxidative Stress / Q000187:drug effects*; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000633:toxicity*
D000975:Antioxidants; D015853:Cysteine Proteinase Inhibitors; D004151:Dipeptides; D007659:Ketones; D018809:Proliferating Cell Nuclear Antigen; D014409:Tumor Necrosis Factor-alpha; C057383:MDL 201053; D005688:Galactosamine; D053148:Caspase 3; D005978:Glutathione